Artificial Intelligence (AI) Enabled Drug Discovery and Clinical Trials

Artificial Intelligence (AI) Enabled Drug Discovery and Clinical Trials Market Research Report: Forecast (2021-2026)

By Component (Software, Service), By Application (Data Aggregation and Analysis, Clinical Trials, Drug Design, Drug Characterization, Biomarker Research), By Therapeutic Application (Oncology, Cardiov Read more

  • Healthcare
  • Jul 2021
  • 221
  • HC55019A

Artificial Intelligence (AI) Enabled Drug Discovery & Clinical Trials involves collecting information regarding various potential drug entities, formulating their design, followed by planning and pre-clinical trials execution. It helps in saving time, cost, and human efforts in the drug developmental process.

The “Global Artificial Intelligence (AI) Enabled Drug Discovery and Clinical Trials Market” is likely to grow at a CAGR of around 23.6% during the forecast period, i.e., 2021-26, says MarkNtel Advisors. The market growth primarily attributes to the rising demand for reducing the cost of novel drug discovery and their production.  Additionally, the adoption of artificial intelligence is significantly increasing, as faster, efficient, and cost-effective drug discovery is gaining momentum amongst the pharmaceutical industry stakeholders.

The research report, “Global Artificial Intelligence (AI) Enabled Drug Discovery and Clinical Trials Market Analysis, 2021,” states that the burgeoning volume of data generated by the molecule screening processes & preclinical studies is another crucial factor fueling the adoption of artificial intelligence, thereby propelling the market growth.

Report Coverage Details
Study Period Historical Data: 2016-19
Base Year: 2020
Forecast Period: 2021-26
CAGR 23.6%
Regions Covered North America: USA, Canada, Mexico
Europe:  Germany, UK, France, Italy, Spain
Asia-Pacific: China, India, Japan, South Korea, Australia and Others
South America: Brazil, and Argentina
Middle East & Africa: UAE, Saudi Arabia
Key Companies Profiled Accutar Biotechnology, Ardigen, Atomwise Inc., AiCure, LLC, Berg LLc, Cloud Pharmaceuticals, Biovista, Cyclica Inc., Symphony Innovations, GNS Healthcare
Unit Denominations USD Million/Billion

 

Global Artificial Intelligence (AI) Enabled Drug Discovery and Clinical Trials Market Have positively impacted by COVID-19 Pandemic

With the global Covid-19 pandemic outbreak in early 2020, the pharma and biotech companies have increasingly turned to artificial intelligence to enhance precision and speed in drug development. The pandemic has set the stage for massive investments toward fast development and trials of drugs.

Moreover, the adoption of artificial intelligence helps in offering a high level of precision to the complicated and time-consuming discovery phase in the drug development process, thereby leading to faster development of drugs and lower failure risk.

  1. Introduction
    1. Product Definition
    2. Research Process
    3. Glossary
    4. Market Segmentation
  2. Executive Summary
  3. Start-up Ecosystem
  4. Impact of COVID-19 on Global Artificial Intelligence (AI) Enabled Drug Discovery and Clinical Trials Market
  5. Expert Verbatim- Interview Excerpts of 10 industry experts
  6. Global Artificial Intelligence (AI) Enabled Drug Discovery and Clinical Trials Market Outlook, 2016-2026F
    1. Market Size & Analysis
      1. By Revenues
    2. Market Share & Analysis
      1. By Component
        1. Software
        2. Service
      2.  By Application
        1. Data Aggregation and Analysis
        2. Clinical Trials
        3. Drug Design
        4. Drug Characterization
        5. Biomarker Research
      3.  By Therapeutic Application
        1. Oncology
        2. Cardiovascular Disease
        3. Nervous System Disease
        4. Respiratory Disorder
        5. Metabolic Disorder
        6. Immunologic Disease
        7. Infectious Disease
        8. Others
      4.  By End-User
        1. Biopharmaceutical Industry
        2. Contract Research Organization (CROs)
        3. Academic Institutes and Research Centers
      5. By Region
        1. North America
        2. South America
        3. Europe
        4. Asia-Pacific
        5. Middle East & Africa
      6. By Company
        1. Revenue Shares
        2. Strategic Factorial Indexing
        3. Competitor Placement in MarkNtel Quadrant
  7. North America Artificial Intelligence (AI) Enabled Drug Discovery and Clinical Trials Market Outlook, 2016-2026F
    1. Market Size & Analysis
      1. By Revenues
    2. Market Share & Analysis
      1. By Component
      2. By Application
      3. By Therapeutic Application
      4. By End-User
      5. By Country
        1. US
        2. Canada
        3. Mexico
    3. The US Artificial Intelligence (AI) Enabled Drug Discovery and Clinical Trials Market Outlook, 2016-2026F
      1. Market Size & Analysis
        1. By Revenues
      2. Market Share & Analysis
        1. By Component
        2. By Application
    4. Canada Artificial Intelligence (AI) Enabled Drug Discovery and Clinical Trials Market Outlook, 2016-2026F
      1. Market Size & Analysis
        1. By Revenues
      2. Market Share & Analysis
        1. By Component
        2. By Application
    5. Mexico Artificial Intelligence (AI) Enabled Drug Discovery and Clinical Trials Market Outlook, 2016-2026F
      1. Market Size & Analysis
        1. By Revenues
      2. Market Share & Analysis
        1. By Component
        2. By Application
  8. South America Artificial Intelligence (AI) Enabled Drug Discovery and Clinical Trials Market Outlook, 2016-2026F
    1. Market Size & Analysis
      1. By Revenues
    2. Market Share & Analysis
      1. By Component
      2. By Application
      3. By Therapeutic Application
      4. By End-User
      5. By Country
        1. Brazil
        2. Argentina
        3. Others
    3. Brazil Artificial Intelligence (AI) Enabled Drug Discovery and Clinical Trials Market Outlook, 2016-2026F
      1. Market Size & Analysis
        1. By Revenues
      2. Market Share & Analysis
        1. By Component
        2. By Application
    4. Argentina Artificial Intelligence (AI) Enabled Drug Discovery and Clinical Trials Market Outlook, 2016-2026F
      1. Market Size & Analysis
        1. By Revenues
      2. Market Share & Analysis
        1. By Component
        2. By Application
  9. Europe Artificial Intelligence (AI) Enabled Drug Discovery and Clinical Trials Market Outlook, 2016-2026F
    1. Market Size & Analysis
      1. By Revenues
    2. Market Share & Analysis
      1. By Component
      2. By Application
      3. By Therapeutic Application
      4. By End-User
      5. By Country
        1. The UK
        2. Germany
        3. France
        4. Italy
        5. Spain
        6. Others
    3. UK Artificial Intelligence (AI) Enabled Drug Discovery and Clinical Trials Market Outlook, 2016-2026F
      1. Market Size & Analysis
        1. By Revenues
      2. Market Share & Analysis
        1. By Component
        2. By Application
    4. Germany Artificial Intelligence (AI) Enabled Drug Discovery and Clinical Trials Market Outlook, 2016-2026F
      1. Market Size & Analysis
        1. By Revenues
      2. Market Share & Analysis
        1. By Component
        2. By Application
    5. France Artificial Intelligence (AI) Enabled Drug Discovery and Clinical Trials Market Outlook, 2016-2026F
      1. Market Size & Analysis
        1. By Revenues
      2. Market Share & Analysis
        1. By Component
        2. By Application
    6. Italy Artificial Intelligence (AI) Enabled Drug Discovery and Clinical Trials Market Outlook, 2016-2026F
      1. Market Size & Analysis
        1. By Revenues
      2. Market Share & Analysis
        1. By Component
        2. By Application
    7. Spain Artificial Intelligence (AI) Enabled Drug Discovery and Clinical Trials Market Outlook, 2016-2026F
      1. Market Size & Analysis
        1. By Revenues
      2. Market Share & Analysis
        1. By Component
        2. By Application
  10. Asia-Pacific Artificial Intelligence (AI) Enabled Drug Discovery and Clinical Trials Market Outlook, 2016-2026F
    1. Market Size & Analysis
      1. By Revenues
    2. Market Share & Analysis
      1. By Component
      2. By Application
      3. By Therapeutic Application
      4. By End-User
      5. By Country
        1. China
        2. India
        3. Japan
        4. Australia
        5. South Korea
        6. Others
  11. China Artificial Intelligence (AI) Enabled Drug Discovery and Clinical Trials Market Outlook, 2016-2026F
    1. Market Size & Analysis
      1. By Revenues
    2. Market Share & Analysis
      1. By Component
      2. By Application
  12. India Artificial Intelligence (AI) Enabled Drug Discovery and Clinical Trials Market Outlook, 2016-2026F
    1. Market Size & Analysis
      1. By Revenues
    2. Market Share & Analysis
      1. By Component
      2. By Application
  13. Japan Artificial Intelligence (AI) Enabled Drug Discovery and Clinical Trials Market Outlook, 2016-2026F
    1. Market Size & Analysis
      1. By Revenues
    2. Market Share & Analysis
      1. By Component
      2. By Application
  14. Australia Artificial Intelligence (AI) Enabled Drug Discovery and Clinical Trials Market Outlook, 2016-2026F
    1. Market Size & Analysis
      1. By Revenues
    2. Market Share & Analysis
      1. By Component
      2. By Application
  15. South Korea Artificial Intelligence (AI) Enabled Drug Discovery and Clinical Trials Market Outlook, 2016-2026F
    1. Market Size & Analysis
      1. By Revenues
    2. Market Share & Analysis
      1. By Component
      2. By Application
  16. Middle East and Africa Artificial Intelligence (AI) Enabled Drug Discovery and Clinical Trials Market Outlook, 2016-2026F
    1. Market Size & Analysis
      1. By Revenues
    2. Market Share & Analysis
      1. By Component
      2. By Application
      3. By Therapeutic Application
      4. By End-User
      5. By Country
        1. UAE
        2. Saudi Arabia
        3. Others
  17. UAE Artificial Intelligence (AI) Enabled Drug Discovery and Clinical Trials Market Outlook, 2016-2026F
    1. Market Size & Analysis
      1. By Revenues
    2. Market Share & Analysis
      1. By Component
      2. By Application
  18. Saudi Arabia Artificial Intelligence (AI) Enabled Drug Discovery and Clinical Trials Market Outlook, 2016-2026F
    1. Market Size & Analysis
      1. By Revenues
    2. Market Share & Analysis
      1. By Component
      2. By Application
  19. Global Artificial Intelligence (AI) Enabled Drug Discovery and  Clinical Trials Dynamics
    1. Drivers
    2. Challenges
    3. Impact Analysis
  20. Global Artificial Intelligence (AI) Enabled Drug Discovery and Clinical Trials Regulations, Product Standards
  21. Global Artificial Intelligence (AI) Enabled Drug Discovery and Clinical Trials Value Chain Analysis
  22. Global Artificial Intelligence (AI) Enabled Drug Discovery and Clinical Trials Intellectual Property Rights Analysis
  23. Global Artificial Intelligence (AI) Enabled Drug Discovery and Clinical Trials Hotspots & Opportunities
  24. Competition Outlook
    1. Competitor Wise Growth Strategies
      1. Product Portfolio
      2. Brand Specialization
      3. Target Markets
      4. Research & Development
      5. Strategic Alliances & Initiatives
    2. Company Profiles
      1. Accutar Biotechnology
      2. Ardigen
      3. Atomwise Inc.
      4. AiCure, LLC
      5. Berg LLc
      6. Cloud Pharmaceuticals
      7. Biovista
      8. Cyclica Inc.
      9. Symphony Innovations
      10. GNS Healthcare
  25. Disclaimer
Artificial Intelligence (AI) Enabled Drug Discovery And Clinical Trials Market Segmentation
*This field is required